ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인공임신중절약 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.3%로 성장할 전망이며, 493억 7,000만 달러로 성장이 예측됩니다. 예측 기간 동안 전망되는 성장은 원격의료 서비스 확대, 자유주의 지역에서의 정부지원 증가, 여성건강과 관련된 신흥기업에 대한 투자 증가, 자기관리를 통한 인공임신중절 수용 확대, 헬스케어의 디지털화 진전 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 약물 전달 기술 혁신, 디지털 배합 플랫폼 대두, AI 주도 원격 상담 도구, 임신중절 케어를 위한 모바일 헬스 애플리케이션, 임신중절 후 모니터링을 위한 웨어러블 기술 등이 있습니다.
예기치 않은 임신 증가는 향후 수년간 인공임신중절약 시장의 성장을 가속할 것으로 예측됩니다. 계획 외 임신이란 임신 시 의도나 계획 없이 발생하는 임신을 말하며, 대부분의 경우 피임도구의 일관성 없는 사용이나 잘못된 사용으로 인한 것입니다. 이러한 증가는 피임에 대한 접근이 제한된 것이 주요 원인이며, 비용, 교육 부족, 불충분한 헬스케어 인프라 등의 장벽이 효과적인 피임 사용을 방해하고 있습니다. 인공임신중절약은 계획되지 않은 임신을 관리하기 위한 안전하고 비외과적인 해결책을 제공하고, 개인의 생식에 관한 자율성을 높이며, 침습적인 처치의 필요성을 최소화하며, 임상과 가정 모두에서 시기적절한 의료 접근을 확보합니다. 예를 들어 2022년 3월 유엔인구기금(UNFPA)은 전 세계 전체 임신의 약 절반, 연간 약 1억 2,100만 명이 계획 외 임신이라고 보고했습니다. 이처럼 계획 밖의 임신 증가가 인공임신중절약 시장 확대에 박차를 가하고 있습니다.
인공임신중절약 시장의 주요 기업은 환자를 위한 합리적인 가격과 가용성을 높이기 위해 헤마베이트의 일반 버전과 같은 혁신적인 제품 개발을 선호합니다. 헤마베이트 제네릭 의약품은 자궁 수축을 유발하기 위해 사용되는 헤마베이트 선발품을 대체하는 저비용 의약품입니다. 산후 출혈 관리에 효과적이며 안전하고 효율적인 약을 통한 인공임신중절을 도와줍니다. 예를 들어, 미국 제약회사인 롱그로브 파마슈티컬스 LLC는 2022년 11월 자궁애토니로 인한 산후출혈을 치료하기 위한 보다 저렴하고 구하기 쉬운 선택지로 Pfizer사의 헤마베이트 제네릭 의약품인 카보프로스트 트로메타민 주사제를 출시했습니다. 이 약은 또한 자궁 수축에 의한 임신중절 과정을 안전하게 촉진함으로써 약에 의한 임신중절에서도 중요한 역할을 하고 있습니다. 이러한 제네릭 의약품의 발매는, 특히 선발 의약품의 가격이나 입수 가능성에 과제를 안고 있는 지역에서, 헬스케어 비용을 삭감해, 필요 불가결한 인공임신중절 의료에 대한 액세스를 개선하는 데 중요한 한 걸음이 됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 인공임신중절약 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 인공임신중절약 시장 : 성장률 분석
세계의 인공임신중절약 시장 실적 : 규모 및 성장(2019-2024년)
세계의 인공임신중절약 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 인공임신중절약 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 인공임신중절약 시장 : 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
미페프리스톤
미소프로스톨
피토신
헤마베이트
카보프로스트
기타
세계의 인공임신중절약 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내
피하
세계의 인공임신중절약 시장 : 치료 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
의료 인공임신중절
외과적 인공임신중절
세계의 인공임신중절약 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 인공임신중절약 시장 : 미페프리스톤별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제네릭 미페프리스톤
브랜드명 미페프리스톤
미소프로스톨과의 병용
세계의 인공임신중절약 시장 : 미소프로스톨별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구정
질정
설하정
박칼정
세계의 인공임신중절약 시장 : 피토신별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
주사액
정맥내(IV) 투여
근육내(IM) 투여
세계의 인공임신중절약 시장 : 헤마베이트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
주사액
단회 투여 바이알
멀티 도즈 바이알
세계의 인공임신중절약 시장 : 카보프로스트별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
근육내 주사
프리필드 주사기
바이알 폼
세계의 인공임신중절약 시장 : 기타 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
메토트렉세이트
지노프로스톤
에르고메트린
옥시토신 유사체
제7장 지역별 및 국가별 분석
세계의 인공임신중절약 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 인공임신중절약 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
인공임신중절 약 시장 : 경쟁 구도
인공임신중절 약 시장 : 기업 프로파일
Pfizer Inc.
Bayer AG
Intas Pharmaceuticals
Sun Pharmaceutical Industries Ltd.
Macleods Pharmaceuticals Ltd
제31장 기타 주요 기업 및 혁신 기업
Cipla Ltd.
Lupin Ltd.
Zydus Lifesciences Ltd.
Cadila Pharmaceuticals
Alkem Laboratories Ltd.
Shanghai Xinhua Pharmaceutical Co. Ltd.
Medley Pharmaceuticals
Acme Formulations Ltd.
Aristo Pharmaceuticals Pvt. Ltd.
Mankind Pharma Ltd.
Neiss Labs Ltd.
Danco Laboratories LLC
GenBioPro Inc.
Exelgyn SA
Linepharma International Limited
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
인공임신중절약 시장(2029년) : 새로운 기회를 제공하는 국가
인공임신중절약 시장(2029년) : 새로운 기회를 제공하는 부문
인공임신중절약 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Abortion drugs are medications that end a pregnancy by triggering a process similar to a natural miscarriage. They are generally used during the first 10 weeks of pregnancy and are approved in many countries as a safe and effective method for abortion.
The primary categories of abortion drugs include mifepristone, misoprostol, pitocin, hemabate, carboprost, among others. Mifepristone is taken orally and works by blocking the hormone progesterone, leading to the breakdown of the uterine lining and ending early pregnancy. These medications can be administered through oral, intravenous, or subcutaneous routes. They are used for therapeutic purposes such as medical and surgical abortion. The drugs are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.
The abortion drugs market research report is one of a series of new reports from The Business Research Company that provides abortion drugs market statistics, including abortion drugs industry global market size, regional shares, competitors with an abortion drugs market share, detailed abortion drugs market segments, market trends and opportunities, and any further data you may need to thrive in the abortion drugs industry. The abortion drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The abortion drugs market size has grown rapidly in recent years. It will grow from $28.79 billion in 2024 to $32.15 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historic period can be attributed to a rise in unintended pregnancies, increased awareness of reproductive rights, higher demand for non-surgical abortion methods, population growth and urbanization, and wider availability of generic formulations.
The abortion drugs market size is expected to see rapid growth in the next few years. It will grow to $49.37 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The projected growth in the forecast period can be credited to the expansion of telehealth services, increased government support in liberal regions, rising investment in women's health startups, growing acceptance of self-managed abortions, and the advancement of healthcare digitization. Key trends expected during this period include innovations in drug delivery technologies, the rise of digital prescription platforms, AI-driven teleconsultation tools, mobile health applications for abortion care, and wearable technology for post-abortion monitoring.
The increasing occurrence of unplanned pregnancies is expected to drive the growth of the abortion drug market in the coming years. Unplanned pregnancies are those that occur without intent or planning at the time of conception, often due to inconsistent or incorrect use of contraceptives. This rise is largely attributed to limited access to contraception, with barriers such as cost, lack of education, and insufficient healthcare infrastructure hindering effective birth control use. Abortion drugs offer a safe, non-surgical solution to manage unplanned pregnancies, empowering individuals with greater reproductive autonomy, minimizing the need for invasive procedures, and ensuring timely healthcare access both in clinical and home settings. For example, in March 2022, the United Nations Population Fund (UNFPA) reported that nearly half of all pregnancies worldwide, around 121 million annually, are unplanned. Thus, the growing number of unplanned pregnancies is fueling the expansion of the abortion drug market.
Leading companies in the abortion drug market are prioritizing the development of innovative products, such as generic versions of hemabate, to enhance affordability and accessibility for patients. Generic hemabate is a lower-cost alternative to the original Hemabate drug, used to induce uterine contractions. It is effective in managing postpartum bleeding and supports safe and efficient medical abortions. For example, in November 2022, Long Grove Pharmaceuticals LLC, a US-based pharmaceutical company, introduced carboprost tromethamine injection, the generic equivalent of Pfizer's Hemabate, as a more affordable and accessible option for treating postpartum hemorrhage caused by uterine atony. This medication also plays a vital role in medical abortion by safely facilitating the termination process through uterine contractions. The launch of such generic alternatives marks an important step in reducing healthcare costs and improving access to essential abortion care, particularly in regions facing challenges with the affordability and availability of branded medications.
In March 2024, CVS Health Corp, a US-based pharmacy company, partnered with Walgreens Boots Alliance Inc. to start offering the abortion pill mifepristone in stores across various states. Through this collaboration, CVS and Walgreens seek to expand access to reproductive healthcare by making the medication available at numerous retail locations, thereby supporting women's right to choose amid increasing legal limitations on abortion. Walgreens Boots Alliance Inc. is a US-based retail company that delivers pharmacy, health, and wellness products and services through its broad store network.
Major players in the abortion drugs market are Pfizer Inc., Bayer AG, Intas Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Ltd, Cipla Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Cadila Pharmaceuticals, Alkem Laboratories Ltd., Shanghai Xinhua Pharmaceutical Co. Ltd., Medley Pharmaceuticals, Acme Formulations Ltd., Aristo Pharmaceuticals Pvt. Ltd., Mankind Pharma Ltd., Neiss Labs Ltd., Danco Laboratories LLC, GenBioPro Inc., Exelgyn SA, Linepharma International Limited, Adorshea.
North America was the largest region in the abortion drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in abortion drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the abortion drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The abortion drugs market consists of sales of prostaglandin analogs, anti-progestogens, anti-progestogens, non-steroidal anti-inflammatory drugs (NSAIDs), analgesics and sedatives. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Abortion Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on abortion drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for abortion drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The abortion drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Mifepristone ; Misoprostol ; Pitocin; Hemabate; Carboprost; Other Drug Classes
2) By Route Of Administration: Oral; Intravenous; Subcutaneous
3) By Therapeutic Application: Medical Abortion; Surgical Abortion
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Mifepristone: Generic Mifepristone; Branded Mifepristone; Combination With Misoprostol
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Abortion Drugs Market Characteristics
3. Abortion Drugs Market Trends And Strategies
4. Abortion Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Abortion Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Abortion Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Abortion Drugs Market Growth Rate Analysis
5.4. Global Abortion Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Abortion Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Abortion Drugs Total Addressable Market (TAM)
6. Abortion Drugs Market Segmentation
6.1. Global Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mifepristone
Misoprostol
Pitocin
Hemabate
Carboprost
Other Drug Classes
6.2. Global Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
6.3. Global Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Abortion
Surgical Abortion
6.4. Global Abortion Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Abortion Drugs Market, Sub-Segmentation Of Mifepristone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Generic Mifepristone
Branded Mifepristone
Combination With Misoprostol
6.6. Global Abortion Drugs Market, Sub-Segmentation Of Misoprostol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Vaginal Tablets
Sublingual Tablets
Buccal Tablets
6.7. Global Abortion Drugs Market, Sub-Segmentation Of Pitocin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Solution
Intravenous (IV) Administration
Intramuscular (IM) Administration
6.8. Global Abortion Drugs Market, Sub-Segmentation Of Hemabate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Solution
Single-Dose Vials
Multi-Dose Vials
6.9. Global Abortion Drugs Market, Sub-Segmentation Of Carboprost, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intramuscular Injection
Prefilled Syringes
Vial Form
6.10. Global Abortion Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Methotrexate
Dinoprostone
Ergometrine
Oxytocin Analogs
7. Abortion Drugs Market Regional And Country Analysis
7.1. Global Abortion Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Abortion Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Abortion Drugs Market
8.1. Asia-Pacific Abortion Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Abortion Drugs Market
9.1. China Abortion Drugs Market Overview
9.2. China Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Abortion Drugs Market
10.1. India Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Abortion Drugs Market
11.1. Japan Abortion Drugs Market Overview
11.2. Japan Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Abortion Drugs Market
12.1. Australia Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Abortion Drugs Market
13.1. Indonesia Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Abortion Drugs Market
14.1. South Korea Abortion Drugs Market Overview
14.2. South Korea Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Abortion Drugs Market
15.1. Western Europe Abortion Drugs Market Overview
15.2. Western Europe Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Abortion Drugs Market
16.1. UK Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Abortion Drugs Market
17.1. Germany Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Abortion Drugs Market
18.1. France Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Abortion Drugs Market
19.1. Italy Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Abortion Drugs Market
20.1. Spain Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Abortion Drugs Market
21.1. Eastern Europe Abortion Drugs Market Overview
21.2. Eastern Europe Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Abortion Drugs Market
22.1. Russia Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Abortion Drugs Market
23.1. North America Abortion Drugs Market Overview
23.2. North America Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Abortion Drugs Market
24.1. USA Abortion Drugs Market Overview
24.2. USA Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Abortion Drugs Market
25.1. Canada Abortion Drugs Market Overview
25.2. Canada Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Abortion Drugs Market
26.1. South America Abortion Drugs Market Overview
26.2. South America Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Abortion Drugs Market
27.1. Brazil Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Abortion Drugs Market
28.1. Middle East Abortion Drugs Market Overview
28.2. Middle East Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Abortion Drugs Market
29.1. Africa Abortion Drugs Market Overview
29.2. Africa Abortion Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Abortion Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Abortion Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Abortion Drugs Market Competitive Landscape And Company Profiles
30.1. Abortion Drugs Market Competitive Landscape
30.2. Abortion Drugs Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Intas Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Macleods Pharmaceuticals Ltd Overview, Products and Services, Strategy and Financial Analysis
31. Abortion Drugs Market Other Major And Innovative Companies
31.1. Cipla Ltd.
31.2. Lupin Ltd.
31.3. Zydus Lifesciences Ltd.
31.4. Cadila Pharmaceuticals
31.5. Alkem Laboratories Ltd.
31.6. Shanghai Xinhua Pharmaceutical Co. Ltd.
31.7. Medley Pharmaceuticals
31.8. Acme Formulations Ltd.
31.9. Aristo Pharmaceuticals Pvt. Ltd.
31.10. Mankind Pharma Ltd.
31.11. Neiss Labs Ltd.
31.12. Danco Laboratories LLC
31.13. GenBioPro Inc.
31.14. Exelgyn SA
31.15. Linepharma International Limited
32. Global Abortion Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Abortion Drugs Market
34. Recent Developments In The Abortion Drugs Market
35. Abortion Drugs Market High Potential Countries, Segments and Strategies
35.1 Abortion Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Abortion Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Abortion Drugs Market In 2029 - Growth Strategies
